Handelsbanken Fonder’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-24,500
Closed -$734K 1581
2023
Q1
$734K Buy
24,500
+6,000
+32% +$198K ﹤0.01% 815
2022
Q4
$566K Buy
+18,500
New +$555K ﹤0.01% 899
2021
Q2
Sell
-32,900
Closed -$918K 1709
2021
Q1
$918K Hold
32,900
0.01% 880
2020
Q4
$816K Hold
32,900
0.01% 912
2020
Q3
$688K Hold
32,900
0.01% 843
2020
Q2
$505K Buy
+32,900
New +$416K ﹤0.01% 957

Other funds holding CC

Handelsbanken Fonder's CC Position: Q2 2023 in Review

Handelsbanken Fonder sold out of Chemours (CC) in Q2 2023, closing a stake of 24,500 shares — an estimated $734K sold.

Handelsbanken Fonder first reported a position in CC in Q2 2020 and held it in 6 quarters. The position peaked at $918K in Q1 2021. 476 funds tracked by Wall St. Rank hold CC as of Q2 2023.

  • Handelsbanken Fonder reported no remaining Chemours position as of Q2 2023 after selling out during the quarter.
  • Handelsbanken Fonder sold 24,500 Chemours shares in Q2 2023, an estimated $734K.
  • Handelsbanken Fonder first reported a position in Chemours in Q2 2020 and held it in 6 quarters.
  • Handelsbanken Fonder's Chemours position peaked at $918K in Q1 2021.
  • 476 funds tracked by Wall St. Rank held Chemours as of Q2 2023.

Based on Handelsbanken Fonder's 13F filing for Q2 2023, filed 2 Aug 2023.